Skip to main content
NCBI home page
Molecular and Cellular Biology logoLink to Molecular and Cellular Biology
. 1986 Oct;6(10):3341–3348. doi: 10.1128/mcb.6.10.3341

Differential response to retinoic acid of Syrian hamster embryo fibroblasts expressing v-src or v-Ha-ras oncogenes.

A M Jetten, J C Barrett, T M Gilmer
PMCID: PMC367079  PMID: 3025589

Abstract

It has been shown that treatment of many but not all tumor cell lines with retinoids affects cell proliferation and expression of the transformed phenotype. To determine whether the response of the tumor cell to retinoids is influenced by specific oncogenes activated in the cell, we studied the action of these agents in the immortal, nontumorigenic Syrian hamster embryo cell lines DES-4 and 10W transfected with either v-Ha-ras or v-src oncogenes. In this paper we show that in transformed DES-4 cells expressing v-src, retinoic acid inhibited anchorage-independent growth, reduced saturation density, and inhibited the induction of ornithine decarboxylase by the phorbol ester 12-O-tetradecanoylphorbol-13-acetate. In contrast, retinoic acid enhances the expression of the transformed phenotype in DES-4-derived cells that express v-Ha-ras. In these cells retinoic acid increases the number and the average size of colonies formed in soft agar. Moreover, retinoic acid enhances ornithine decarboxylase activity and acts in a synergistic fashion with 12-O-tetradecanoylphorbol-13-acetate. These results indicate that oncogenes activated in cells can indeed influence the response of cells to retinoids. Retinoic acid does not appear to alter the levels of pp60src or p21ras proteins in these cells, suggesting that retinoic acid does not affect the synthesis of these oncogene products. Furthermore, retinoic acid does not affect the protein kinase activity of pp60src. Transformed cell lines derived from 10W cells responded differently, indicating that the presence of a specific oncogene is not the only factor determining the response to retinoids. Possible mechanisms by which retinoic acid may interfere with the expression of the oncogene products are discussed.

Full text

PDF
3341

Images in this article

3342Image
on p.3342
3347Image
on p.3347

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anzano M. A., Roberts A. B., De Larco J. E., Wakefield L. M., Assoian R. K., Roche N. S., Smith J. M., Lazarus J. E., Sporn M. B. Increased secretion of type beta transforming growth factor accompanies viral transformation of cells. Mol Cell Biol. 1985 Jan;5(1):242–247. doi: 10.1128/mcb.5.1.242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bishop J. M. Viral oncogenes. Cell. 1985 Aug;42(1):23–38. doi: 10.1016/s0092-8674(85)80098-2. [DOI] [PubMed] [Google Scholar]
  3. Cooper G. M., Lane M. A. Cellular transforming genes and oncogenesis. Biochim Biophys Acta. 1984;738(1-2):9–20. doi: 10.1016/0304-419x(84)90017-9. [DOI] [PubMed] [Google Scholar]
  4. Giese N. A., Neary K. E., Levine N., Lindell T. J., Duffy J. J. Inhibition by retinoic acid of murine retrovirus-induced cellular transformation and tumor formation. J Natl Cancer Inst. 1985 May;74(5):1135–1144. [PubMed] [Google Scholar]
  5. Gilmer T. M., Annab L. A., Oshimura M., Barrett J. C. Neoplastic transformation of normal and carcinogen-induced preneoplastic Syrian hamster embryo cells by the v-src oncogene. Mol Cell Biol. 1985 Jul;5(7):1707–1713. doi: 10.1128/mcb.5.7.1707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gilmer T. M., Erikson R. L. Development of anti-pp60src serum with antigen produced in Escherichia coli. J Virol. 1983 Jan;45(1):462–465. doi: 10.1128/jvi.45.1.462-465.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Heldin C. H., Westermark B. Growth factors: mechanism of action and relation to oncogenes. Cell. 1984 May;37(1):9–20. doi: 10.1016/0092-8674(84)90296-4. [DOI] [PubMed] [Google Scholar]
  8. Higuchi M., Yoshida F. Lowry determination of protein in the presence of sulfhydryl compounds or other reducing agents. Anal Biochem. 1977 Feb;77(2):542–547. doi: 10.1016/0003-2697(77)90271-8. [DOI] [PubMed] [Google Scholar]
  9. Hiragun A., Sato M., Mitsui H. Effects of retinoids on the proliferation of murine sarcoma virus-transformed cells in serum-free culture: potentiation of autocrine stimulation. Cancer Lett. 1984 May;23(1):19–28. doi: 10.1016/0304-3835(84)90057-0. [DOI] [PubMed] [Google Scholar]
  10. Jetten A. M. Action of retinoids on the anchorage-independent growth of normal rat kidney fibroblasts induced by 12-O-tetradecanoylphorbol-13-acetate or sarcoma growth factor. Cancer Res. 1983 Jan;43(1):68–72. [PubMed] [Google Scholar]
  11. Jetten A. M., De Luca L. M. Studies on antagonistic actions of TPA and retinoic acid. Carcinog Compr Surv. 1982;7:513–518. [PubMed] [Google Scholar]
  12. Jetten A. M., Goldfarb R. H. Action of epidermal growth factor and retinoids on anchorage-dependent and -independent growth of nontransformed rat kidney cells. Cancer Res. 1983 May;43(5):2094–2099. [PubMed] [Google Scholar]
  13. Jetten A. M. Modulation of cell growth by retinoids and their possible mechanisms of action. Fed Proc. 1984 Jan;43(1):134–139. [PubMed] [Google Scholar]
  14. Jetten A. M. Retinoids specifically enhance the number of epidermal growth factor receptors. Nature. 1980 Apr 17;284(5757):626–629. doi: 10.1038/284626a0. [DOI] [PubMed] [Google Scholar]
  15. Jetten A. M., Shirley J. E. Retinoids antagonize the induction of ornithine decarboxylase activity by phorbol esters and phospholipase C in rat tracheal epithelial cells. J Cell Physiol. 1985 Jun;123(3):386–394. doi: 10.1002/jcp.1041230314. [DOI] [PubMed] [Google Scholar]
  16. Krycève-Martinerie C., Lawrence D. A., Crochet J., Jullien P., Vigier P. Cells transformed by Rous sarcoma virus release transforming growth factors. J Cell Physiol. 1982 Dec;113(3):365–372. doi: 10.1002/jcp.1041130304. [DOI] [PubMed] [Google Scholar]
  17. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  18. Land H., Parada L. F., Weinberg R. A. Cellular oncogenes and multistep carcinogenesis. Science. 1983 Nov 18;222(4625):771–778. doi: 10.1126/science.6356358. [DOI] [PubMed] [Google Scholar]
  19. Lotan R. Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochim Biophys Acta. 1980 Mar 12;605(1):33–91. doi: 10.1016/0304-419x(80)90021-9. [DOI] [PubMed] [Google Scholar]
  20. McLachlan J. A., Wong A., Degen G. H., Barrett J. C. Morphologic and neoplastic transformation of Syrian hamster embryo fibroblasts by diethylstilbestrol and its analogs. Cancer Res. 1982 Aug;42(8):3040–3045. [PubMed] [Google Scholar]
  21. O'Brien T. G., Diamond L. Ornithine decarboxylase induction and DNA synthesis in hamster embryo cell cultures treated with tumor-promoting phorbol diesters. Cancer Res. 1977 Nov;37(11):3895–3900. [PubMed] [Google Scholar]
  22. Ozanne B., Fulton R. J., Kaplan P. L. Kirsten murine sarcoma virus transformed cell lines and a spontaneously transformed rat cell-line produce transforming factors. J Cell Physiol. 1980 Oct;105(1):163–180. doi: 10.1002/jcp.1041050118. [DOI] [PubMed] [Google Scholar]
  23. Reynolds S. H., Stowers S. J., Maronpot R. R., Anderson M. W., Aaronson S. A. Detection and identification of activated oncogenes in spontaneously occurring benign and malignant hepatocellular tumors of the B6C3F1 mouse. Proc Natl Acad Sci U S A. 1986 Jan;83(1):33–37. doi: 10.1073/pnas.83.1.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Roberts A. B., Anzano M. A., Lamb L. C., Smith J. M., Sporn M. B. Antagonistic actions of retinoic acid and dexamethasone on anchorage-independent growth and epidermal growth factor binding of normal rat kidney cells. Cancer Res. 1984 Apr;44(4):1635–1641. [PubMed] [Google Scholar]
  25. Roberts A. B., Roche N. S., Sporn M. B. Selective inhibition of the anchorage-independent growth of myc-transfected fibroblasts by retinoic acid. Nature. 1985 May 16;315(6016):237–239. doi: 10.1038/315237a0. [DOI] [PubMed] [Google Scholar]
  26. Seifter E., Rettura G., Padawer J., Demetriou A. A., Levenson S. Antipyretic and antiviral action of vitamin A in Moloney sarcoma virus- and poxvirus-inoculated mice. J Natl Cancer Inst. 1976 Aug;57(2):355–359. doi: 10.1093/jnci/57.2.355. [DOI] [PubMed] [Google Scholar]
  27. Seifter E., Zisblatt M., Levine N., Rettura G. Inhibitory action of vitamin A on a murine sarcoma. Life Sci. 1973 Oct 1;13(7):945–952. doi: 10.1016/0024-3205(73)90084-2. [DOI] [PubMed] [Google Scholar]
  28. Thomassen D. G., Gilmer T. M., Annab L. A., Barrett J. C. Evidence for multiple steps in neoplastic transformation of normal and preneoplastic Syrian hamster embryo cells following transfection with Harvey murine sarcoma virus oncogene (v-Ha-ras). Cancer Res. 1985 Feb;45(2):726–732. [PubMed] [Google Scholar]
  29. Verma A. K., Shapas B. G., Rice H. M., Boutwell R. K. Correlation of the inhibition by retinoids of tumor promoter-induced mouse epidermal ornithine decarboxylase activity and of skin tumor promotion. Cancer Res. 1979 Feb;39(2 Pt 1):419–425. [PubMed] [Google Scholar]
  30. Wilson E. L., Reich E. Plasminogen activator in chick fibroblasts: induction of synthesis by retinoic acid; synergism with viral transformation and phorbol ester. Cell. 1978 Oct;15(2):385–392. doi: 10.1016/0092-8674(78)90007-7. [DOI] [PubMed] [Google Scholar]

Articles from Molecular and Cellular Biology are provided here courtesy of Taylor & Francis

RESOURCES